ESPE Abstracts

Sickle cell anemia (SCA) is the most common subtype of sickle cell disease (SCD) worldwide of The disease is highly prevalent in Sub Saharan Africa with a prevalence rate of 3% in Nigeria; a country with a population of over 180 million. Growth failure is a recognized clinical feature in SCA patients which culminates to short stature if unaddressed. Late presentation/age at diagnosis is one of the daunting challenges. Despite the high prevalence of children with SCA in Wes...